About the role
At Novartis Global Health & Sustainability (GH&S), we have a long-standing history in addressing global health challenges. Over the past 20 years, our approach has evolved from purely donation-based to also include other models with more sustainable social impact. Today, we apply our expertise and full organizational capabilities to address major, unresolved global health challenges. In India, our GH&S team is focused on improving healthcare for underserved populations through our long-standing Arogya Parivar (AP) program, a community health program which addresses social issues that impact access to healthcare.
Our AP Global Health work is currently focused on two key disease areas - Sickle Cell Disease (SCD) and Leprosy. Under our AP program we plan to support the government of India\'s goal to increase access to SCD services in tribal communities. To this effect, we are working with the government to determine how we can best help strengthen health systems and improve access to effective SCD care for these communities including access to affordable medicines.
Novartis donations of multidrug therapy to the WHO have been a cornerstone for global elimination efforts, leading to the treatment of more than 7.3 million leprosy patients worldwide since 2000. The government of India has set forth a vision for a \xe2\x80\x9cleprosy-free India\xe2\x80\x9d through the National Leprosy Eradication Program, with a mission to provide free quality leprosy services to all sections of the population. Arogya Parivar will support the government of India in reaching its leprosy elimination goals by building on our company\'s long-standing expertise in the field and leveraging our experience in expanding access and communities and enhancing our current donation program
Key Responsibilities
MNCJobsIndia.com will not be responsible for any payment made to a third-party. All Terms of Use are applicable.